Applied Therapeutics, Inc. — Director's Dealing 2024

Aug 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2024-08-05

Reporting Person: Shendelman Shoshana (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-05	Common Stock	G	747886	—	Disposed	0	Indirect
2024-08-05	Common Stock	G	747886	—	Acquired	747886	Indirect
2024-08-12	Common Stock	S	300000	$5.98	Disposed	5167853	Direct
2024-08-13	Common Stock	S	357423	$6.18	Disposed	4810430	Direct
2024-08-14	Common Stock	S	119591	$5.93	Disposed	4690839	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1492094	Indirect
Common Stock	290280	Indirect
Common Stock	88397	Indirect

Footnotes

F1: Through a grantor retained annuity trust. Upon termination of the trust, 747,886 shares of the issuer's common stock were distributed to a family trust controlled by the reporting person. The remaining shares were distributed to the reporting person and continue to be reported in this Form 4 as directly owned.

F2: Through a family trust controlled by the reporting person.

F3: Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.57 to $6.205, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F4: Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.82 to $6.39, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F5: Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.825 to $6.265, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F6: Through a family trust controlled by the reporting person.

F7: Through a family trust controlled by the reporting person.

F8: Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.